INSTITUTION'S PROFILE

Braxia Health, Mississauga, ON, Canada.

Publications (1)

Brain-derived neurotrophic factor Val66Met and CYP2B6 polymorphisms as predictors for ketamine effectiveness in patients with treatment-resistant depression.

Journal: Journal of psychopharmacology (Oxford, England)

Publication date: 

Journal: Journal of psychopharmacology (Oxford, England)

Publication Year: 

Authors & Co-authors:  Rodrigues Chen-Li Di Vincenzo Juneja Pinder McIntyre Rosenblat